| 1 |
Botulinum toxin for the management of depression: An updated review of the evidence and meta-analysis |
|
| | Jara Schulze, Insa Neumann, Michelle Magid, Eric Finzi, Christopher Sinke, M. Axel Wollmer, Tillmann H.C. Krüger | | | Journal of Psychiatric Research. 2021; 135: 332 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Pooled Subject-Reported Outcomes From 2 Phase 3 Studies of OnabotulinumtoxinA for Simultaneous Treatment of Forehead and Glabellar Lines |
|
| | Patricia Ogilvie, Alexander Z. Rivkin, Steven Dayan, Steven G. Yoelin, Kristin E. Larsen, Sepideh Varon, Julie K. Garcia | | | Dermatologic Surgery. 2020; 46(7): 950 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
“Masking” our emotions: Botulinum toxin, facial expression, and well-being in the age of COVID-19 |
|
| | Mark S. Nestor, Daniel Fischer, David Arnold | | | Journal of Cosmetic Dermatology. 2020; 19(9): 2154 | | | [Pubmed] [Google Scholar] [DOI] | |
|
